273 related articles for article (PubMed ID: 22011088)
1. Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women.
Goldstein BL; Chibnik LB; Karlson EW; Costenbader KH
Autoimmunity; 2012 Mar; 45(2):161-8. PubMed ID: 22011088
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
Bertrand KA; Birmann BM; Chang ET; Spiegelman D; Aster JC; Zhang SM; Laden F
Blood; 2010 Nov; 116(18):3547-53. PubMed ID: 20647565
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
5. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
6. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
Cortese M; Leng Y; Bjornevik K; Mitchell M; Healy BC; Mina MJ; Mancuso JD; Niebuhr DW; Munger KL; Elledge SJ; Ascherio A
JAMA Neurol; 2024 May; 81(5):515-524. PubMed ID: 38497939
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.
Alspaugh MA; Henle G; Lennette ET; Henle W
J Clin Invest; 1981 Apr; 67(4):1134-40. PubMed ID: 6259211
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis.
Masuoka S; Kusunoki N; Takamatsu R; Takahashi H; Tsuchiya K; Kawai S; Nanki T
PLoS One; 2018; 13(12):e0208957. PubMed ID: 30533036
[TBL] [Abstract][Full Text] [Related]
10. Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies.
Westergaard MW; Draborg AH; Troelsen L; Jacobsen S; Houen G
Biomed Res Int; 2015; 2015():472174. PubMed ID: 26000294
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and rheumatoid arthritis.
Balandraud N; Roudier J; Roudier C
Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.
Catalano MA; Carson DA; Slovin SF; Richman DD; Vaughan JH
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5825-8. PubMed ID: 230491
[TBL] [Abstract][Full Text] [Related]
15. Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study.
Svendsen AJ; Westergaard MCW; Draborg AH; Holst R; Kyvik KO; Jakobsen MA; Junker P; Houen G
Front Immunol; 2021; 12():650713. PubMed ID: 33777048
[No Abstract] [Full Text] [Related]
16. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.
Toussirot E; Roudier J
Joint Bone Spine; 2007 Oct; 74(5):418-26. PubMed ID: 17625943
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
18. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
Camargo MC; Kim KM; Matsuo K; Torres J; Liao LM; Morgan D; Michel A; Waterboer T; Song M; Gulley ML; Dominguez RL; Yatabe Y; Kim S; Cortes-Martinez G; Lissowska J; Zabaleta J; Pawlita M; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):414-419. PubMed ID: 31719065
[TBL] [Abstract][Full Text] [Related]
19. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
20. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
Wagner HJ; Munger KL; Ascherio A
Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]